University of Calgary
Calgary, Alberta, Canada
Dr. May Choi is a rheumatologist and Associate Professor at the Cumming School of Medicine, University of Calgary. She is also the Associate Director of Mitogen Advanced Diagnostics Laboratory and Director of the AI.Dx Laboratories. Dr. Choi's current research interests are focused on biomarker discovery and validation for prediction of clinical outcomes systemic autoimmune rheumatic diseases. She completed a Lupus Fellowship at the Brigham and Women's Hospital and MPH at Harvard University.
Friday, October 24, 2025
4:10 PM – 4:30 PM Central Time
Disclosure information not submitted.
Friday, October 24, 2025
4:30 PM – 4:50 PM Central Time
Disclosure information not submitted.
Friday, October 24, 2025
4:50 PM – 5:10 PM Central Time
Disclosure information not submitted.
Friday, October 24, 2025
5:10 PM – 5:30 PM Central Time
Disclosure information not submitted.
2025 ACR Guidelines for the Treatment of Extrarenal Systemic Lupus Erythematosus (SLE)
Sunday, October 26, 2025
9:00 AM – 10:30 AM Central Time
Disclosure(s): AstraZeneca: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Celltrion: Consultant (Terminated, January 1, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2024); GlaxoSmithKlein(GSK): Consultant (Terminated, January 2, 2023); Mallickrodt Pharmaceuticals: Consultant (Terminated, January 2, 2023); MitogenDx: Consultant (Ongoing); Organon: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2024); Werfen: Consultant (Ongoing)
Bench to Bedside in the Diagnosis and Treatment of Lupus Nephritis
Monday, October 27, 2025
1:00 PM – 2:30 PM Central Time
Disclosure(s): AstraZeneca: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Celltrion: Consultant (Terminated, January 1, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2024); GlaxoSmithKlein(GSK): Consultant (Terminated, January 2, 2023); Mallickrodt Pharmaceuticals: Consultant (Terminated, January 2, 2023); MitogenDx: Consultant (Ongoing); Organon: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2024); Werfen: Consultant (Ongoing)
Prevention Is the Best Medicine: Updates for Rheumatoid Arthritis and Lupus
Monday, October 27, 2025
2:30 PM – 4:00 PM Central Time
Disclosure(s): AstraZeneca: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Celltrion: Consultant (Terminated, January 1, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2024); GlaxoSmithKlein(GSK): Consultant (Terminated, January 2, 2023); Mallickrodt Pharmaceuticals: Consultant (Terminated, January 2, 2023); MitogenDx: Consultant (Ongoing); Organon: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2024); Werfen: Consultant (Ongoing)
Getting to the Heart of the Issue: Perimyocarditis in Autoimmune Diseases
Tuesday, October 28, 2025
1:00 PM – 2:00 PM Central Time
Disclosure(s): AstraZeneca: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Celltrion: Consultant (Terminated, January 1, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2024); GlaxoSmithKlein(GSK): Consultant (Terminated, January 2, 2023); Mallickrodt Pharmaceuticals: Consultant (Terminated, January 2, 2023); MitogenDx: Consultant (Ongoing); Organon: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2024); Werfen: Consultant (Ongoing)
